OBJECTIVE: To determine whether the association between multiple sclerosis (MS) and Leber hereditary optic neuropathy (LHON) (known as "Harding disease") is a chance finding, or the 2 disorders are mechanistically linked. METHODS: We performed a United Kingdom-wide prospective cohort study of prevalent cases of MS with LHON mitochondrial DNA (mtDNA) mutations. The new cases were compared with published cases, enabling a comprehensive clinical description. We also performed a meta-analysis of studies screening patients with MS for LHON mtDNA mutations to find evidence of a genetic association. RESULTS: Twelve new patients were identified from 11 pedigrees, and 44 cases were identified in the literature. The combined cohort had the following characteristics: multiple episodes of visual loss, predominance for women, and lengthy time interval before the fellow eye is affected (average 1.66 years), which is very atypical of LHON; conversely, most patients presented without eye pain and had a poor visual prognosis, which is unusual for optic neuritis associated with MS. The number of UK cases of LHON-MS fell well within the range predicted by the chance occurrence of MS and the mtDNA mutations known to cause LHON. There was no association between LHON mtDNA mutations and MS in a meta-analysis of the published data. CONCLUSIONS: Although the co-occurrence of MS and LHON mtDNA mutations is likely to be due to chance, the resulting disorder has a distinct phenotype, implicating a mechanistic interaction. Patients with LHON-MS have a more aggressive course, and prognostication and treatment should be guarded.
OBJECTIVE: To determine whether the association between multiple sclerosis (MS) and Leber hereditary optic neuropathy (LHON) (known as "Harding disease") is a chance finding, or the 2 disorders are mechanistically linked. METHODS: We performed a United Kingdom-wide prospective cohort study of prevalent cases of MS with LHON mitochondrial DNA (mtDNA) mutations. The new cases were compared with published cases, enabling a comprehensive clinical description. We also performed a meta-analysis of studies screening patients with MS for LHON mtDNA mutations to find evidence of a genetic association. RESULTS: Twelve new patients were identified from 11 pedigrees, and 44 cases were identified in the literature. The combined cohort had the following characteristics: multiple episodes of visual loss, predominance for women, and lengthy time interval before the fellow eye is affected (average 1.66 years), which is very atypical of LHON; conversely, most patients presented without eye pain and had a poor visual prognosis, which is unusual for optic neuritis associated with MS. The number of UK cases of LHON-MS fell well within the range predicted by the chance occurrence of MS and the mtDNA mutations known to cause LHON. There was no association between LHON mtDNA mutations and MS in a meta-analysis of the published data. CONCLUSIONS: Although the co-occurrence of MS and LHON mtDNA mutations is likely to be due to chance, the resulting disorder has a distinct phenotype, implicating a mechanistic interaction. Patients with LHON-MS have a more aggressive course, and prognostication and treatment should be guarded.
Authors: A E Harding; M G Sweeney; D H Miller; C J Mumford; H Kellar-Wood; D Menard; W I McDonald; D A Compston Journal: Brain Date: 1992-08 Impact factor: 13.501
Authors: P Cortelli; P Montagna; G Pierangeli; R Lodi; P Barboni; R Liguori; V Carelli; S Iotti; P Zaniol; E Lugaresi; B Barbiroli Journal: J Neurol Sci Date: 1997-05-01 Impact factor: 3.181
Authors: Liesbeth Spruijt; Dinanda N Kolbach; Rene F de Coo; Astrid S Plomp; Noel J Bauer; Hubertus J Smeets; Christine E M de Die-Smulders Journal: Am J Ophthalmol Date: 2006-04 Impact factor: 5.258
Authors: F Perez; O Anne; S Debruxelles; P Menegon; V Lambrecq; D Lacombe; M L Martin-Negrier; B Brochet; C Goizet Journal: Clin Neurol Neurosurg Date: 2008-10-09 Impact factor: 1.876
Authors: T Klopstock; G Metz; P Yu-Wai-Man; B Büchner; C Gallenmüller; M Bailie; N Nwali; P G Griffiths; B von Livonius; L Reznicek; J Rouleau; N Coppard; T Meier; P F Chinnery Journal: Brain Date: 2013-02-06 Impact factor: 13.501
Authors: C A P F Alves; A Goldstein; S R Teixeira; J S Martin-Saavedra; I P de Barcelos; G Fadda; L Caschera; M Kidd; F G Gonçalves; E M McCormick; M J Falk; Z Zolkipli-Cunningham; A Vossough; G Zuccoli Journal: AJNR Am J Neuroradiol Date: 2020-12-31 Impact factor: 3.825